Phase 3 Study of Humira for Ulcerative Colitis - ONA
Links shared publicly online about this topic.
- 303total visits
Phase 3 Study of Humira for Ulcerative Colitis - ONA
View full resource at oncologynurseadvisor.com
Tags: IBD, Crohn's Disease Medication, Ulcerative Colitis, Rheumatoid Arthritis Medication, Phase 3 Clinical Trial, Humira, Ulcer, Colitis
Most Recently Shared on May 10, 2011 at 4:22 pm By:
Phase 3 Study of Humira for Ulcerative Colitis http://goo.gl/fb/L0Brd
Phase 3 Study of Uceris for Ulcerative Colitis - MPR
empr.com — “Santarus, Inc. announced pooled data from two Phase 3 studies of Uceris (budesonide MMX) for the induction of remission of mild or moderate active ulcerative colitis.” View full resource at empr.com
Most Recently Shared on November 1, 2011 at 7:30 pm By:
Phase 3 Study of Uceris for Ulcerative #Colitis http://t.co/PLaOXrl5
Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints In Phase III Ulcerative Colitis Study
medicalnewstoday.com — “Abbott's (NYSE: ABT) HUMIRA® (adalimumab) met its primary endpoint of clinical remission in a Phase III study of adult patients with moderate to severe ulcerative colitis. Results were presen” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2011 at 7:05 am By:
Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints In Phase III Ulcerative Colitis Study http://mnt.to/3VGk #crohns #ibd
New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis
jnj.com — “Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.” View full resource at jnj.com
Most Recently Shared on May 10, 2011 at 7:22 pm By:
eyeonfda Pharma and Health Lawyer
New Phase 3 Study Results 4 REMICADE® in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis - http://ow.ly/4RvIc
Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study: May 10, 2011
abbott.com — “Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study: May 10, 2011” View full resource at abbott.com
Most Recently Shared on May 10, 2011 at 7:20 pm By:
eyeonfda Pharma and Health Lawyer
Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study - http://ow.ly/4RvB8
Phase 3 Study of Humira for Ulcerative Colitis - MPR
empr.com — “Abbott announced new data from its Phase 3 study of Humira (adalimumab) for the treatment of moderate to severe ulcerative colitis (UC).” View full resource at empr.com
Most Recently Shared on May 10, 2011 at 3:54 pm By:
MPR News: Phase 3 Study of Humira for Ulcerative Colitis: Abbott announced new data from its Phase 3 study of Hu... http://bit.ly/j6rBma
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - MPR
empr.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).” View full resource at empr.com
Most Recently Shared on May 10, 2011 at 3:54 pm By:
MPR News: Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients: Centocor Ortho Biotech announc... http://bit.ly/mK0h6c
New Phase 3 Study Results Show Remicade Is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis - Drugs.com MedNews
drugs.com — “Study Findings Demonstrate Clinical Response with REMICADE in Pediatric Patients Who Have Not Responded to Conventional Therapy Chicago, IL, May 9, 2011 - Data” View full resource at drugs.com
Most Recently Shared on May 10, 2011 at 2:12 pm By:
Drugs and Devices OW OW Health
New Phase 3 Study Results Show Remicade Is Effective in the Treatment of Pediatric Patients With Moderate ... http://bit.ly/kusZrR #drug
Santarus and Cosmo Announce Positive Top-Line Results in U.S. Phase III Clinical Study Evaluating Budesonide MMX in Ulcerative Colitis - Drugs.com MedNews
drugs.com — “Companies Expect to Announce European Phase III Study Results in November Extended Use Study is Ongoing Sep 29, 2010 - Santarus, Inc. (NASDAQ SNTS) and Cosmo Ph” View full resource at drugs.com
Most Recently Shared on September 30, 2010 at 8:08 pm By:
Drugs and Devices OW OW Health
Santarus and Cosmo Announce Positive Top-Line Results in U.S. Phase III Clinical Study Evaluating Budesonide ... http://bit.ly/c3kwaA #drug
Advertisement
